Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information on how we use and manage cookies please take a look at our privacy and cookie policies. Some parts of the site may not work properly if you choose not to accept cookies.

sections
Home > Cymfony > Pharmaceutical Social Media Marketing: Risks and Regulatory Issues
 

Pharmaceutical Social Media Marketing: Risks and Regulatory Issues

White Paper Published By: Cymfony
Cymfony
Published:  Sep 13, 2007
Type:  White Paper
Length:  27 pages

The pharmaceutical industry is very interested in using social media to promote products, services and issues important to it. However, many drug firm executives are uncertain about how to tackle the legal and regulatory issues associated with social media communications.



Tags : 
health, healthcare, pharmaceuticals, pharmaceutical, social media, fda, compliance, cymfony